The Bureau of Customs (BOC) has taken custody of two fuel tankers that were allegedly involved in the illegal fuel transfer or “paihi” scheme, at Navotas Fish Port. In a news release on Thursday, the ...

She previously worked as an editorial assistant at PEOPLE from 2018 to 2022. Todd Williamson/Getty While Lily Collins is all grown up and a celebrity in her own right, she’ll always be Phil Coll ...

The wedge salad is a steakhouse icon. Follow this step-by-step recipe and make the classic steakhouse salad in your home ...

MANILA, Philippines — The Bureau of Customs (BOC) confiscated smuggled fresh onions worth P2 million at the Port of Manila on Thursday, the agency said on Sunday. The shipment from China was ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their medical records for safety reasons, a move that comes as it builds a case ...

ICBC and BOC line up issuance plans for 60 billion yuan worth of total loss-absorbing capacity (TLAC) bonds as Chinese G-SIBs (global systemically important banks) are expected to sell 440 billion ...

Eli Lilly has become a household name thanks to breakthrough diabetes and obesity care medicines. The stock has trounced the broader market over the past year, and shares have become a bit pricey.

Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring sales thanks to its dominance in the high-growth weight loss drug market.

Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic diseases. But the deal is a little different compared to many recent ...

Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its competitor. Eli Lilly (LLY) has partnered with the government of the ...

An exciting partnership in Indianapolis has just been announced: Eli Lilly and Company has reached a multi-year partnership ...

On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 and older. The medication is an injectable branded Ebglyss and will be ...